Yingliang Dai

Towards an expanded neurocognitive account of ketamine's rapid antidepressant effects.

The International Journal of Neuropsychopharmacology February 4, 2025 Yingliang Dai, Ben J. Harrison, Christopher G. Davey et al. 6 citations

Ketamine is an N-methyl-D-aspartate receptor antagonist that has shown effectiveness as a rapidly acting treatment for depression. Although advances have been made in understanding ketamine's antidepressant pharmacological and molecular mechanisms of action, the large-scale neurocognitive mechanisms driving its therapeutic effects are less clearly understood. To help provide such a framework,...